OnkoSight Advanced™ Next-generation Sequencing (NGS) for Multiple Myeloma
NGS panel helps provide a more detailed evaluation of multiple myeloma genetics and may help identify additional abnormalities that may be of prognostic and/or therapeutic value. OnkoSight Advanced™ is your state-of-the-art NGS from GenPath. Combined with GenPath’s comprehensive test menu, OnkoSight Advanced™ will help empower physicians to make informed decisions effectively and efficiently.